Comparative Pharmacology
Head-to-head clinical analysis: HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydrocodone is a semi-synthetic opioid agonist that binds to mu-opioid receptors in the CNS, altering pain perception and emotional response to pain. Pseudoephedrine is a sympathomimetic amine that acts as a decongestant by stimulating alpha-adrenergic receptors in the respiratory tract mucosa, causing vasoconstriction.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
One tablet (hydrocodone bitartrate 5 mg/pseudoephedrine HCl 60 mg) orally every 4 to 6 hours as needed for pain and nasal congestion; maximum: 4 tablets per day.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Hydrocodone terminal elimination half-life is approximately 3.8–4.5 hours in adults. Pseudoephedrine half-life is about 4–6 hours, but may be prolonged to 10–20 hours in patients with acidic urine or renal impairment. The combination product's half-life reflects individual components.
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Hydrocodone is primarily excreted renally as unchanged drug and metabolites (norhydrocodone, hydromorphone, conjugated metabolites); about 26% of a dose is excreted in urine as unchanged hydrocodone and about 25% as norhydrocodone. Pseudoephedrine is predominantly excreted unchanged in urine (55–75%) with the remainder as N-demethylated metabolites; renal excretion is pH-dependent, with acidic urine enhancing elimination. Biliary/fecal excretion is minimal for both components.
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic